SCHEMBL21023182

SCHEMBL21023182

O=c1c2cc3c(cc2n(Cc2ccccc2)c2c(-c4ccccc4)cccc12)c(=O)c1cccc(-c2ccccc2)c1n3Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX4 Q99571 2/20 0.53
▸ NTRK1 P04629 1/20 0.48
▸ MAPT P10636 5/20 0.44
▸ ATM Q13315 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.43
▸ LMNA P02545 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ CYP19A1 P11511 1/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ PIM2 Q9P1W9 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21023176 0.84 ALDH1A1 (0.49) P2RX4MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL21023177 0.80 ALDH1A1 (0.47) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL28041337 0.77 P2RX4 (0.86) P2RX4NTRK1MAPTALDH1A1LMNA
SCHEMBL21023175 0.77 HSD17B10 (0.50) NTRK1ATMLMNASMN1; SMN2KMT2A
SCHEMBL21023168 0.76 ALDH1A1 (0.49) MAPTALDH1A1KDM4ETDP1RECQL
SCHEMBL21023172 0.75 MAPK1 (0.40) MAPTATMALDH1A1LMNASMN1; SMN2
SCHEMBL21167118 0.74 P2RX4 (0.48) P2RX4NTRK1MAPTALDH1A1LMNA
SCHEMBL21023174 0.73 CDC25A (0.50) KDM4EHSD17B10
SCHEMBL21023320 0.72 HSD17B10 (0.52) NTRK1MAPTATMMEN1KMT2A
SCHEMBL21023181 0.72 POLB (0.42) P2RX4MAPTALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190157350-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190157350-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND CRY1, CDH1, TEAD1 P2RX4 2293/4885NTRK1 4202/4885MAPT 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback